{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:07:01Z","timestamp":1779577621667,"version":"3.53.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,20]]},"abstract":"<jats:p>\n                    This study aims to explore the nomogram risk prediction model for chemotherapy prognosis of patients with non-small cell lung cancer (NSCLC) based on clinical features and pathological parameters, and its clinical application value. Patients with NSCLC were randomly divided into a training set (n\u2005=\u2005168) and a validation set (n\u2005=\u200572) according to the ratio of 7:3. In the training set, multivariate logistic regression was used to analyze the risk factors of chemotherapy prognosis and build a nomogram prediction model. Receiver operating characteristic curve and calibration curve were drawn to evaluate the prediction efficiency of the nomogram model, which was verified in the validation set. Among the 168 patients in the training set, 68 (40.48%) had a poor prognosis, while 30 (41.67%) of the 72 patients in the validation set had a poor prognosis. There was no significant difference in the incidence, clinical features, and pathological parameters between the training set and the validation set (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). The results of univariate analysis showed that there were significant differences in age, hypertension, smoking history, cough, hemoptysis, dyspnea, tumor diameter, histological subtypes, contact area between tumor and blood vessels, and short diameter of lymph nodes between patients with poor prognosis and patients with good prognosis in the training set (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Multivariate logistic regression analysis showed that age, cough, hemoptysis, dyspnea, tumor diameter, histological subtypes, and contact area between tumor and blood vessels were independent risk factors for poor prognosis (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). Further construct the nomogram prediction model; the nomogram model has good calibration and fitting degree between prediction and reality in the training set and validation set (C-index is 0.923 and 0.947). The results of the Hosmer\u2013Lemeshow test are \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u200510.692,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.219 and \u03c7\n                    <jats:sup>2<\/jats:sup>\n                    \u2005=\u20056.350,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.608, respectively; the area under the curve of the nomogram model in predicting poor prognosis is 0.918 (95% confidence interval: 0.870\u20130.966) and 0.946 (95% confidence interval: 0.887\u20131.000). The model shows good calibration and fitting in both the training set and validation set, and can accurately predict the prognosis of patients with NSCLC after chemotherapy, which can provide valuable reference for clinicians to formulate individualized treatment plans and evaluate the prognosis of patients.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047382","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:00:58Z","timestamp":1771628458000},"page":"e47382","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Construction and validation of a nomogram for predicting chemotherapy prognosis in non-small cell lung cancer patients based on clinical features and pathological parameters: An observational study"],"prefix":"10.1097","volume":"105","author":[{"given":"Sanhu","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongshi","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Yun","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5720-3148","authenticated-orcid":false,"given":"Xiangbing","family":"Xin","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, The Second Affiliated Hospital of Air Force Medical University, Xi\u2019an, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends.","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"115891","DOI":"10.1016\/j.biopha.2023.115891","article-title":"Advances and challenges in the treatment of lung cancer.","volume":"169","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2147\/COPD.S380732","article-title":"From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis.","volume":"17","author":"Qi","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/cac2.12359","article-title":"Non-small cell lung cancer in China.","volume":"42","author":"Chen","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"e13705","DOI":"10.1111\/crj.13705","article-title":"Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion.","volume":"18","author":"Wang","year":"2024","journal-title":"Clin Respir J"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s12325-024-02799-9","article-title":"Clinical management of patients with non-small cell lung cancer, brain metastases, and actionable genomic alterations: a systematic literature review.","volume":"41","author":"Khasraw","year":"2024","journal-title":"Adv Ther"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/1759-7714.14779","article-title":"Chemotherapy: a partnership with immunotherapy in non-small cell lung cancer.","volume":"14","author":"Mendes","year":"2023","journal-title":"Thorac Cancer"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.annonc.2023.07.001","article-title":"Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial.","volume":"34","author":"Felip","year":"2023","journal-title":"Ann Oncol"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccell.2023.12.013","article-title":"Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer.","volume":"42","author":"Memon","year":"2024","journal-title":"Cancer Cell"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1007\/s00330-023-09813-8","article-title":"Multiparametric MRI for evaluation of pathological response to the neoadjuvant chemo-immunotherapy in resectable non-small-cell lung cancer.","volume":"33","author":"Bao","year":"2023","journal-title":"Eur Radiol"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12905-023-02848-5","article-title":"Prognostic nomograms for breast cancer with lung metastasis: a SEER-based population study.","volume":"24","author":"Xie","year":"2024","journal-title":"BMC Womens Health"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/stmcls\/sxac011","article-title":"Erk5 in bone marrow mesenchymal stem cells regulates bone homeostasis by preventing osteogenesis in adulthood.","volume":"40","author":"Horie","year":"2022","journal-title":"Stem Cells"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"106660","DOI":"10.1016\/j.cmpb.2022.106660","article-title":"Prediction of lung cancer risk based on age and smoking history.","volume":"216","author":"Bates","year":"2022","journal-title":"Comput Methods Programs Biomed"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13019-022-01806-w","article-title":"Robotic-assisted thoracoscopic resection of anterior mediastinal cystic teratoma: a case report and literature review.","volume":"17","author":"Ramcharran","year":"2022","journal-title":"J Cardiothorac Surg"},{"key":"R15-20260523","first-page":"e40586","article-title":"Carcinoid tumor presenting as hemoptysis and elevated diaphragm.","volume":"15","author":"Shah","year":"2023","journal-title":"Cureus"},{"key":"R16-20260523","first-page":"e49940","article-title":"Effect of prehabilitation in lung cancer patients undergoing lobectomy: a review.","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtcvs.2020.09.146","article-title":"A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.","volume":"163","author":"Suzuki","year":"2022","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40644-023-00565-8","article-title":"Post-neoadjuvant treatment pancreatic cancer resectability and outcome prediction using CT, 18F-FDG PET\/MRI and CA 19-9.","volume":"23","author":"Yoo","year":"2023","journal-title":"Cancer Imaging"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.3390\/ijms24043441","article-title":"Tumor mutational burden for predicting prognosis and therapy outcome of hepatocellular carcinoma.","volume":"24","author":"Gabbia","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-022-01754-x","article-title":"Blood-based tumor mutational burden as a biomarker for atezolizumab in non-small cell lung cancer: the phase 2 B-F1RST trial.","volume":"28","author":"Kim","year":"2022","journal-title":"Nat Med"},{"key":"R21-20260523","first-page":"620","article-title":"Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions.","volume":"73","author":"Megyesfalvi","year":"2023","journal-title":"CA Cancer J Clin"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T23:01:44Z","timestamp":1779577304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047382","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,20]]},"assertion":[{"value":"2025-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}